UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060475
Receipt number R000069186
Scientific Title External validation of the SPAU2 score for 1-year risk stratification in acute type A intramural hematoma: a temporally distinct single-center cohort study
Date of disclosure of the study information 2026/02/01
Last modified on 2026/01/27 08:09:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

External validation of the SPAU2 score for 1-year risk stratification in acute type A intramural hematoma: a temporally distinct single-center cohort study

Acronym

External validation of the risk score for acute type A intramural hematoma

Scientific Title

External validation of the SPAU2 score for 1-year risk stratification in acute type A intramural hematoma: a temporally distinct single-center cohort study

Scientific Title:Acronym

External validation of the risk score for acute type A intramural hematoma

Region

Japan


Condition

Condition

acute type A intramural hematoma

Classification by specialty

Cardiology Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To externally validate the SPAU2 score in a newly established, temporally distinct cohort from the same institution.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

cardiovascular death or operation within 1-year after onset of type A IMH

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Consecutive acute type A intramural hematoma patients who received initial medical management

Key exclusion criteria

those who received urgent surgery

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Shigetaka
Middle name
Last name Kageyama

Organization

Shizuoka City Shizuoka Hospital

Division name

Department of Cardiology

Zip code

4208630

Address

10-93 Ohtemachi Aoi-ku Shizuoka

TEL

054-253-3125

Email

shigenewf@yahoo.co.jp


Public contact

Name of contact person

1st name Shigetaka
Middle name
Last name Kageyama

Organization

Shizuoka City Shizuoka Hospital

Division name

Department of Cardiology

Zip code

4208630

Address

10-93 Ohtemachi Aoi-ku Shizuoka

TEL

0542533125

Homepage URL


Email

shigenewf@yahoo.co.jp


Sponsor or person

Institute

Shizuoka City Shizuoka Hospital

Institute

Department

Personal name

SHIGETAKA KAGEYAMA


Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shizuoka City Shizuoka Hospital

Address

10-93 Ohtemachi Aoi-ku Shizuoka

Tel

054-253-3125

Email

chiken2@shizuokahospital.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

85

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2007 Year 11 Month 19 Day

Date of IRB

2020 Year 04 Month 16 Day

Anticipated trial start date

2008 Year 01 Month 01 Day

Last follow-up date

2026 Year 01 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2026 Year 01 Month 27 Day

Last modified on

2026 Year 01 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069186